SQAP inhibited vascular endothelial growth factor (VEGF)-dependent FAK phosphorylation in human umbilical vein endothelial cells (HUVEC) as well as fibronectin-dependent FAK phosphorylation in A549 lung cancer cells. The gene discussed is VEGFA; the disease is lung carcinoma.